MyMedR

Displaying all 4 publications

Abstract:

Sort:

Graphene and graphene oxide as a docking station for modern drug delivery system

Muthoosamy K, Bai RG, Manickam S

Curr Drug Deliv, 2014;11(6):701-18.
PMID: 24909150

Motivated by the success and exhaustive research on carbon nanotubes (CNTs) based drug delivery, graphene, a two-dimensional; honey-comb crystal lattice has emerged as the rising star in recent years. Graphene is a flat monolayer of carbon atoms that holds many promising properties such as unparalleled thermal conductivity, remarkable electronic properties, and most intriguingly higher planar surface and superlative mechanical strength, which are attractive in biotechnological applications. Delivery of anti-cancer drugs using graphene and its derivatives has sparked major interest in this emerging field. The anti-cancer therapies often pose a limitation of insolubility, administration problems and cell penetration ability. In addition, systemic toxicity caused by lack of selective targeting towards cancer cells and inefficient distribution limits its clinical applications. Graphene nanocomposite is a promising tool to address these drawbacks. This review will focus on various synthesis and functionalization of graphene and graphene oxide for providing better solubility and targeted drug delivery at cancer cells. A more advanced and 'smart' graphene hybrid nanostructures that have several functionalities such as stimulus-response mediated delivery, imaging at release sites as well as transfection into cancer cells are also presented. A brief description on the challenges and perspectives for future research in this field is also discussed.
Biosustainable production of nanoparticles via mycogenesis for biotechnological applications: A critical review

Sudheer S, Bai RG, Muthoosamy K, Tuvikene R, Gupta VK, Manickam S

Environ Res, 2022 03;204(Pt A):111963.
PMID: 34450157 DOI: 10.1016/j.envres.2021.111963

The demand for the green synthesis of nanoparticles has gained prominence over the conventional chemical and physical syntheses, which often entails toxic chemicals, energy consumption and ultimately lead to negative environmental impact. In the green synthesis approach, naturally available bio-compounds found in plants and fungi can be effective and have been proven to be alternative reducing agents. Fungi or mushrooms are particularly interesting due to their high content of bioactive compounds, which can serve as excellent reducing agents in the synthesis of nanoparticles. Apart from the economic and environmental benefits, such as ease of availability, low synthesis/production cost, safe and no toxicity, the nanoparticles synthesized from this green method have unique physical and chemical properties. Stabilisation of the nanoparticles in an aqueous solution is exceedingly high, even after prolonged storage with unperturbed size uniformity. Biological properties were significantly improved with higher biocompatibility, anti-microbial, anti-oxidant and anti-cancer properties. These remarkable properties allow further exploration in their applications both in the medical and agricultural fields. This review aims to explore the mushroom-mediated biosynthesis of nanomaterials, specifically the mechanism and bio-compounds involved in the synthesis and their interactions for the stabilisation of nanoparticles. Various metal and non-metal nanoparticles have been discussed along with their synthesis techniques and parameters, making them ideal for specific industrial, agricultural, and medical applications. Only recent developments have been explored in this review.
Fulltext Exceedingly Higher co-loading of Curcumin and Paclitaxel onto Polymer-functionalized Reduced Graphene Oxide for Highly Potent Synergistic Anticancer Treatment

Muthoosamy K, Abubakar IB, Bai RG, Loh HS, Manickam S

Sci Rep, 2016 Sep 06;6:32808.
PMID: 27597657 DOI: 10.1038/srep32808

Metastasis of lung carcinoma to breast and vice versa accounts for one of the vast majority of cancer deaths. Synergistic treatments are proven to be the effective method to inhibit malignant cell proliferation. It is highly advantageous to use the minimum amount of a potent toxic drug, such as paclitaxel (Ptx) in ng/ml together with a natural and safe anticancer drug, curcumin (Cur) to reduce the systemic toxicity. However, both Cur and Ptx suffer from poor bioavailability. Herein, a drug delivery cargo was engineered by functionalizing reduced graphene oxide (G) with an amphiphilic polymer, PF-127 (P) by hydrophobic assembly. The drugs were loaded via pi-pi interactions, resulting in a nano-sized GP-Cur-Ptx of 140 nm. A remarkably high Cur loading of 678 wt.% was achieved, the highest thus far compared to any other Cur nanoformulations. Based on cell proliferation assay, GP-Cur-Ptx is a synergistic treatment (CI
Fulltext Exceedingly biocompatible and thin-layered reduced graphene oxide nanosheets using an eco-friendly mushroom extract strategy

Muthoosamy K, Bai RG, Abubakar IB, Sudheer SM, Lim HN, Loh HS, et al.

Int J Nanomedicine, 2015;10:1505-19.
PMID: 25759577 DOI: 10.2147/IJN.S75213

PURPOSE: A simple, one-pot strategy was used to synthesize reduced graphene oxide (RGO) nanosheets by utilizing an easily available over-the-counter medicinal and edible mushroom, Ganoderma lucidum.
METHODS: The mushroom was boiled in hot water to liberate the polysaccharides, the extract of which was then used directly for the reduction of graphene oxide. The abundance of polysaccharides present in the mushroom serves as a good reducing agent. The proposed strategy evades the use of harmful and expensive chemicals and avoids the typical tedious reaction methods.
RESULTS: More importantly, the mushroom extract can be easily separated from the product without generating any residual byproducts and can be reused at least three times with good conversion efficiency (75%). It was readily dispersible in water without the need of ultrasonication or any surfactants; whereas 5 minutes of ultrasonication with various solvents produced RGO which was stable for the tested period of 1 year. Based on electrochemical measurements, the followed method did not jeopardize RGO's electrical conductivity. Moreover, the obtained RGO was highly biocompatible to not only colon (HT-29) and brain (U87MG) cancer cells, but was also viable towards normal cells (MRC-5).
CONCLUSION: Besides being eco-friendly, this mushroom based approach is easily scalable and demonstrates remarkable RGO stability and biocompatibility, even without any form of functionalization.